Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases

Published:2021-08 Issue:8 Volume:43 Page:1392-1407.e1
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Setyawan Juliana,Mu Fan,Yarur Andres,Zichlin Miriam L.,Yang Hongbo,Fernan Catherine,Billmyer Emma,Downes Nathaniel,Azimi Nassir,Strand Vibeke

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. A Brief Review on Immune Mediated Diseases;Adapa;J Clin Cell Immunol,2011

2. Incidence, survival and prevalence of myeloid malignancies in Europe;Visser;Eur J Cancer,2012

3. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities;El-Gabalawy;J Rheumatol Suppl,2010

4. Immune-mediated disease genetics: the shared basis of pathogenesis;Cotsapas;Trends Immunol,2013

5. Selective JAKinibs: prospects in inflammatory and autoimmune diseases;Virtanen;BioDrugs,2019

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of ankylosing spondylitis with cardiovascular disease: a bidirectional two-sample mendelian randomization study;Frontiers in Genetics;2024-06-26

2. ТРОМБОЕМБОЛІЯ ЛЕГЕНЕВОЇ АРТЕРІЇ У ПАЦІЄНТІВ НА ІНФАРКТ МІОКАРДА: МОЖЛИВОСТІ ТА ЕТАПНІСТЬ ДІАГНОСТИКИ В ЛІКУВАЛЬНОМУ ЗАКЛАДІ, РЕЗУЛЬТАТИ АНТИТРОМБОЛІТИЧНОЇ ТЕРАПІЇ (ВЛАСНІ СПОСТЕРЕЖЕННЯ);Grail of Science;2024-05-01

3. Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE;Thrombosis Journal;2024-04-04

4. Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment;International Journal of Molecular Sciences;2024-03-29

5. Reducing cardiovascular risk in immune‐mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review and meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2024-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3